搜索临床试验以:ARC-520
总计9568个结果
-
Liverpool School of Tropical MedicineLondon School of Hygiene and Tropical Medicine; University of Bergen; Kamuzu University of Health... 和其他合作者完全的
-
M.D. Anderson Cancer Center完全的
-
Novartis PharmaceuticalsBaker Heart and Diabetes Institute完全的
-
Glostrup University Hospital, Copenhagen完全的
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert Einstein College...尚未招聘
-
Medical College of Wisconsin招聘中
-
National Cancer Institute (NCI)招聘中急性髓性白血病 | 既往骨髓增生异常综合征引起的急性髓性白血病 | 继发性急性髓性白血病 | 细胞毒治疗后急性髓系白血病美国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的滤泡性淋巴瘤 | 套细胞淋巴瘤 | 非霍奇金淋巴瘤 | B细胞非霍奇金淋巴瘤 | 成人弥漫性大 B 细胞淋巴瘤 | T 细胞非霍奇金淋巴瘤美国
-
National Institute on Aging (NIA)完全的
-
Lithuanian University of Health SciencesHacettepe University; University of Michigan; University of Messina; Universidad de Granada未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)主动,不招人
-
Mehrdad Abedi, MDNational Cancer Institute (NCI)招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)完全的复发性成人急性髓性白血病 | 缓解期成人急性髓性白血病 | 缓解期儿童急性髓性白血病 | 缓解期成人急性淋巴细胞白血病 | 缓解期儿童急性淋巴细胞白血病 | 复发性成人急性淋巴细胞白血病 | 复发性儿童急性淋巴细胞白血病 | 复发性儿童急性髓性白血病 | 难治性成人急性淋巴细胞白血病 | 母细胞期慢性粒细胞白血病,BCR-ABL1 阳性 | 原始细胞过多的骨髓增生异常综合征 2 | 血统不明的急性白血病 | 急性未分化白血病 | 慢性粒细胞白血病,BCR-ABL1 阳性 | 急性双表型白血病 | 难治性儿童急性淋巴细胞白血病 | 加速期慢性粒细胞白血病,BCR-ABL1 阳性 | 骨髓增生异常综合征伴 Blasts-1美国
-
CHA UniversityHanlim Pharm. Co., Ltd.完全的
-
National Cancer Institute (NCI)完全的伯基特淋巴瘤 | 浆母细胞淋巴瘤 | 弥漫性大 B 细胞淋巴瘤,c-MYC 阳性美国
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials Network完全的
-
Chinese PLA General Hospital309th Hospital of Chinese People's Liberation Army; Beijing Naval General Hospital; Space Center...未知
-
National Institute of Diabetes and Digestive and...Type 1 Diabetes TrialNet完全的
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)招聘中
-
National Cancer Institute (NCI)招聘中临床 III 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8 | 临床 II 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8 | 病理学 II 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8 | 病理学 III 期 HPV 介导的(p16 阳性)口咽癌 AJCC v8美国
-
Korea University Guro HospitalTakeda Pharmaceuticals International, Inc.终止
-
Zhejiang Hisun Pharmaceutical Co. Ltd.未知
-
First Affiliated Hospital Xi'an Jiaotong University尚未招聘
-
Shanghai Zhongshan Hospital招聘中
-
University of EdinburghNHS Lothian; Chief Scientist Office of the Scottish Government完全的
-
Centers for Disease Control and PreventionMinistry of Health and Population, Malawi完全的
-
Poitiers University Hospital完全的
-
Boehringer Ingelheim完全的